http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005511663-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2002-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005511663-A |
| titleOfInvention | Use of farnesyl protein transferase inhibitors in combination with other anti-neoplastic agents for the manufacture of a medicament against cancer |
| abstract | The use of an FPT inhibitor for the manufacture of a medicament for treating cancer is disclosed. This treatment includes the step of administering a therapeutically effective amount of a medicament and a therapeutically effective amount of one or more anti-neoplastic agents, including non-small cell lung cancer, CML, AML, non-Hodgkin's lymphoma and Multiple myeloma is included. The invention also provides a method of treating cancer in a patient in need of treatment for cancer, the method comprising administering a therapeutically effective amount of an FPT inhibitor and an anti-tumor agent selected from the group consisting of: (1) an EGF inhibitor that is an antibody, (2) an EGF inhibitor that is a small molecule, (3) a VEGF inhibitor that is an antibody, and (4) a VEGF inhibitor that is a small molecule. |
| priorityDate | 2001-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.